Today: 16 May 2026
Browse Category

Earnings Reports 6 January 2026

SoFi stock sinks 8% after BofA underperform call; dilution and Jan. 30 earnings in focus

SoFi stock sinks 8% after BofA underperform call; dilution and Jan. 30 earnings in focus

SoFi Technologies shares fell 7.9% to $26.98 Tuesday after Bank of America resumed coverage with an underperform rating and a $20.50 price target. The drop followed news that SoFi sold 57.8 million shares at $27.50 each in a December offering, increasing dilution concerns. Trading volume topped 118 million shares. Goldman Sachs and Barclays also adjusted their price targets, signaling mixed analyst sentiment.
Amphenol (APH) stock steadies after sharp swing with earnings in view

Amphenol (APH) stock steadies after sharp swing with earnings in view

Amphenol shares climbed 0.4% to $140.40 Tuesday after rebounding from an intraday low of $130.70. The company will pay a $0.25 per share dividend Jan. 7 and reports Q4 results Jan. 28. A Zacks note put 2026 earnings estimates at $4 a share and the stock at 35 times forward earnings. Traders watched for stability near $140 as volatility persisted in AI infrastructure stocks.
Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify shares fell 3.3% to $574.00 by midafternoon Tuesday, underperforming the broader market. Trading volume was below average ahead of Friday’s U.S. jobs data. The drop reversed Monday’s gains and put the stock back below $600. Spotify launched a podcast campaign tied to the Golden Globes and introduced a Governors Ball feature in its app.
Microchip stock jumps nearly 10% after chipmaker lifts sales outlook on strong orders

Microchip stock jumps nearly 10% after chipmaker lifts sales outlook on strong orders

Microchip Technology shares jumped 10% to $73.75 Tuesday after the company raised its fiscal Q3 sales forecast to about $1.185 billion, topping its previous outlook. The move followed a 5.6% after-hours gain Monday. CEO Steve Sanghi cited strong bookings and lower internal inventory. The rally boosted other chipmakers, including Texas Instruments and NXP Semiconductors.
Johnson & Johnson stock ticks up on lupus drug data as earnings loom

Johnson & Johnson stock ticks up on lupus drug data as earnings loom

Johnson & Johnson shares rose 0.5% to $205.41 midday Tuesday after reporting positive Phase 2b results for its lupus drug nipocalimab and announcing plans for Phase 3 trials. The company also filed in Europe to expand use of its myeloma drug combo Tecvayli and Darzalex. J&J continues to face pressure from ongoing talc litigation, with more trials expected this year.
Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology shares jumped 10.2% to $73.93 after the company raised its fiscal Q3 net sales outlook to about $1.185 billion, above its prior forecast. CEO Steve Sanghi cited strong bookings and a higher March-quarter backlog. The company will release full results Feb. 5 and filed an 8-K update with regulators. Several analysts raised price targets following the announcement.
Bank of America stock edges higher after Barclays target hike as earnings near

Bank of America stock edges higher after Barclays target hike as earnings near

Bank of America shares rose 0.4% to $57.15 midday Tuesday after Barclays and JPMorgan raised their price targets. Citigroup gained 0.5%, Wells Fargo slipped 0.4%, and JPMorgan was flat. Investors await Friday’s U.S. jobs report and Bank of America’s Jan. 14 earnings for direction. Morgan Stanley filed to launch bitcoin and solana ETFs as banks expand into digital assets.
Lumentum stock whipsaws as accounting chief retirement, Feb. 3 earnings date draw focus

Lumentum stock whipsaws as accounting chief retirement, Feb. 3 earnings date draw focus

Lumentum Holdings shares rose 5.2% to $375.69 in Nasdaq midday trading Tuesday after swinging between $340.46 and $377.65. The company said Chief Accounting Officer Matthew Sepe will retire after the Feb. 6 filing of its quarterly report, with Eric Chang named as successor. About 3.1 million shares traded by midday. Lumentum will release fiscal second-quarter results on Feb. 3.
Citigroup stock holds near 52-week high as Barclays lifts target to $146 ahead of earnings

Citigroup stock holds near 52-week high as Barclays lifts target to $146 ahead of earnings

Citigroup shares edged up 0.1% to $123.42 Tuesday after Barclays raised its price target to $146. Citi hit a 52-week high Monday, closing at $123.30 on heavy volume. The bank will report fourth-quarter results Jan. 14, with analysts expecting earnings of $1.77 per share on $21 billion revenue. Citi disclosed a pre-tax loss from its Russia exit but said it will not affect key capital ratios.
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi Technologies shares dropped 8.9% to $26.68 after a $1.59 billion public offering of 57.8 million shares at $27.50 each. Underwriters included Goldman Sachs, BofA, Citigroup, Deutsche Bank, and Mizuho. Options activity surged, with call volume over three times normal and implied post-earnings moves near 14%. Wall Street remains split on valuation, with price targets ranging from $24 to $28.
JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan shares slipped 0.3% to $333 Tuesday, pulling back after Monday’s record high. The bank’s new Special Advisory Services unit drew attention, while investors await fourth-quarter results due January 13. JPMorgan’s board declared a $1.50 dividend payable January 31 to holders as of January 6. Cost pressures remain a risk, with 2026 expenses projected at $105 billion.
1 155 156 157 158 159 248

Stock Market Today

  • DroneShield ASX:DRO Faces Governance Scrutiny Amid ASIC Probe; Valuation Debate Intensifies
    May 15, 2026, 11:08 PM EDT. DroneShield (ASX:DRO) is under an ASIC investigation over executive share trading and announcements from November 2025, raising governance concerns. Despite strong gains over five years with an 18x total shareholder return, recent stock momentum has waned, dropping 12.1% over 30 days to close at A$3.27. Market debate centers on whether this weakness signals a buying opportunity or reflects baked-in growth risks. The leading valuation narrative pegs fair value at A$8.57, implying significant upside based on scalable defence contracts across NATO and US channels. However, the stock's price-to-sales ratio of 13.9x notably exceeds sector averages, indicating elevated valuation risk if growth falters. Investors should weigh potential procurement timing risks and ASIC probe fallout against the company's positioning in the expanding defence technology market.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop